SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 115 filers reported holding SANA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,834 | -35.1% | 5,125 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $30,545 | +190.3% | 5,125 | +59.3% | 0.00% | 0.0% |
Q1 2023 | $10,523 | -53.6% | 3,218 | -44.0% | 0.00% | 0.0% |
Q4 2022 | $22,685 | -34.2% | 5,743 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $34,458 | -6.7% | 5,743 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $36,927 | -22.2% | 5,743 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $47,437 | -86.8% | 5,743 | -75.3% | 0.00% | -60.0% |
Q4 2021 | $360,467 | -31.3% | 23,286 | 0.0% | 0.01% | -37.5% |
Q3 2021 | $524,401 | +200.7% | 23,286 | +162.5% | 0.01% | +300.0% |
Q2 2021 | $174,384 | +237.2% | 8,870 | +474.1% | 0.00% | +100.0% |
Q1 2021 | $51,711 | – | 1,545 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |